ICD-10 Code C69.50
Malignant neoplasm of unspecified lacrimal gland and duct
C69.50 is a specific ICD-10-CM code used to designate a malignant neoplasm of an unspecified lacrimal gland and duct. The lacrimal system plays a crucial role in producing and draining tears, and primary malignancies within these structures are rare but aggressive forms of orbital cancers. The most common histological subtypes associated with this diagnosis include adenoid cystic carcinoma, adenocarcinoma, and carcinoma ex pleomorphic adenoma. Patients presenting with a lacrimal gland or duct tumor often report a palpable upper eyelid mass, globe displacement or proptosis, localized pain, double vision, or altered tear production. This code applies to primary cancerous growths of the lacrimal apparatus when the specific laterality or detailed ductal location is not stated in the medical record, and it encompasses related conditions such as lacrimal duct carcinoma, malignant mixed tumors of the lacrimal gland, and invasive orbital neoplasms of lacrimal origin.
C69.50 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of unspecified lacrimal gland and duct. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.
See also, ICD-10 Table of Neoplasms.
- MDC 02 Diseases & Disorders of the Eye
Other Disorders of the Eye
ICD-10 code C69.50 is based on the following Tabular structure:
Chapter 2: Neoplasms- Section C69-C72: Malignant neoplasms of eye, brain and other parts of central nervous system
- Category C69: Malignant neoplasm of eye and adnexa
↑ Parent code:
C69.5 for Malignant neoplasm of lacrimal gland and duct
Should you use C69.50 or C6950 (with or without decimal point) when submitting claims?
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you
but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.
This note further define, or give examples of, the content of the code or category.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.